ArticleJournal of clinical medicine2024
Cyclosporin A as an Add-On Therapy to a Corticosteroid-Based Background Treatment in Patients with COVID-19: A Multicenter, Randomized Clinical Trial.
Lucía Llanos Jiménez, Beatriz Alvarez-Alvarez, Eva Fonseca Aizpuru, Germán Peces-Barba, Gloria Pindao Quesada, Mª Jesús Rodríguez Nieto, Francisco J Ruiz-Hornillos, Luis Seijo Maceiras, Ignacio Robles Barrena, Alvaro Mena-de-Cea and 3 more
Abstract read
In one paragraphArticle in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Lucía Llanos JiménezFundación Jiménez Díaz (FJD) University Hospital, FJD Health Research Institute, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.ORCID 0000-0003-3443-7182 Beatriz Alvarez-AlvarezFundación Jiménez Díaz (FJD) University Hospital, FJD Health Research Institute, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.
Germán Peces-BarbaFundación Jiménez Díaz (FJD) University Hospital, FJD Health Research Institute, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.
Gloria Pindao QuesadaVillalba General University Hospital, FJD Health Research Institute, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28400 Madrid, Spain.
Mª Jesús Rodríguez NietoFundación Jiménez Díaz (FJD) University Hospital, FJD Health Research Institute, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.ORCID 0000-0003-4195-9528 Francisco J Ruiz-HornillosInfanta Elena University Hospital, FJD Health Research Institute, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28342 Madrid, Spain.ORCID 0000-0002-0008-1678 Luis Seijo MaceirasClínica Universitaria de Navarra (CUN), 28027 Madrid, Spain.
Ignacio Robles BarrenaRey Juan Carlos University Hospital (HURJC), FJD Health Research Institute, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28933 Madrid, Spain.
Alvaro Mena-de-CeaInternal Medicine Department, A Coruña University Hospital Complex, 15006 A Coruña, Spain.
Olga Sánchez-PernauteFundación Jiménez Díaz (FJD) University Hospital, FJD Health Research Institute, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.
CSACOVID-IISFJD Team
Funding
Fundación Tatiana Pérez de Guzmán el Bueno NA
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19 pneumoniacyclosporin Ahyperinflammationrandomized controlled trial
Identifiers
PMID39274454
PMCPMC11396137
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390